$DXC

DXC earnings ahead amid $2.4 billion insurance unit sale talks

DXC Technology reports Q2 earnings with analysts expecting EPS of $0.55 and revenue of $2.98B, down YoY but up sequentially. The company is in talks to sell its insurance unit for $2.4B. Analysts have a neutral consensus with a $11.21 price target, implying 30% downside. Investors focus on the sale's impact and DXC's core business stability.

Original reporting
Published Oct 29, 2026, 1:46 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 1:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$DXC
Neutral
high confidence
Mentioned
$DXC
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DXCNeutralMed
01

Why it matters

The $2.4 billion divestiture is a significant strategic move that could reshape DXC's financial profile ahead of its earnings release.

02

Market read

First‑time disclosure of a multi‑billion‑dollar sale talks makes this a high‑impact news item for DXC traders.

03

What to watch

Potential impact on employee morale and client contracts during the transition period.

Relevance 8/10Novelty 7/10Timing: ahead of DXC earnings Thursday

Background

DXC is navigating a challenging IT services environment and seeks to streamline operations through the insurance unit sale.

Company-level read

Ticker impact

$DXCNeutralHigh confidence
Context

DXC Technology is in advanced talks to sell its insurance software unit for roughly $2.4 billion, a material M&A development disclosed for the first time.

Expected impact

potential upside if the sale proceeds, but possible pressure from execution risk and debt concerns

Evidence & confidence

Large‑scale sale talks are a fresh catalyst; market will price in deal likelihood and use of proceeds.

Market effects

May signal consolidation in IT services and could affect peers evaluating similar divestitures.

Limited to US tech sector, no broader regional effect.

Modest; primarily relevant to investors in DXC and comparable IT service firms.

Counterpoint

Deal could fall apart, leaving DXC with a weaker balance sheet and heightened execution risk.

Key entities

  • DXC Technology Co

    US‑listed IT services provider.

  • Eldridge Industries

    Potential acquirer of DXC's insurance software unit.

Related articles

$DXCHighAI 9/10

DXC Q2 FY27 slides show earnings beat, but guidance cut sparks selloff

DXC Technology (NYSE:DXC) reported Q2 FY27 earnings beating estimates with $0.67 EPS and $3.03B revenue, but shares fell 17% after-hours due to weak bookings, lower guidance, and a 10% drop in total bookings. The company cut its full-year outlook, citing deal timing and conversion challenges. Despite AI and modernization efforts, organic revenue declined 4.0% YoY, and margins shrank. DXC generated $91M in free cash flow but reduced its FY27 EPS guidance to $2.25-$2.50.

$DXCMedAI 8/10

DXC Technology earnings beat by $0.12, revenue topped estimates

DXC Technology (NYSE: DXC) reported Q2 EPS of $0.67, beating estimates by $0.12, with revenue at $3.03B, surpassing expectations. The company guided Q3 2027 EPS at $0.55, below consensus, and revenue at $2.98B, also below estimates. For FY 2027, DXC expects EPS of $2.25-$2.50 and revenue of $11.91B-$11.98B, both under analyst forecasts. The stock is up 35.50% over 3 months and 17.70% over 12 months.

$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology Co (DXC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 DXC Technology Reports Second Quarter Fiscal Year 2027 Results • Total revenue for Q2 FY27 of $3.03 billion, down 4.0% YoY, down 4.0% on an organic basis (1) • Q2 FY27 EBIT margin of 2.2%, and adjusted EBIT (2) margin of 6.2% • Q2 FY27 Diluted earnings per share of $

$DXCHighAI 8/10

DXC Technology Reports Second Quarter Fiscal Year 2027 Results

DXC Technology reported Q2 FY27 revenue of $3.03B, down 4% YoY. EBIT margin was 2.2%, and adjusted EBIT margin was 6.2%. EPS was $0.15, with non-GAAP EPS at $0.67, down 20.2% YoY. Free cash flow for H1 FY27 was $405M. Bookings were $2.4B, with a 1.0x book-to-bill ratio. The company repurchased $60M in shares and is discussing a possible sale of its insurance business. Guidance for FY27 includes revenue of $11.91B-$11.98B and non-GAAP EPS of $2.25-$2.50.

$DXCHighAI 9/10

Total revenue fell 4% year over year; DXC expects organic revenue to drop about 6% next quarter from a year earlier.

DXC Technology reported Q2 FY27 revenue of $7.45 billion, down 4% YoY, with adjusted EBIT margin of 6.2% and non-GAAP EPS of $0.15. The company expects Q3 organic revenue to drop 6% YoY. CEO Raul Fernandez highlighted progress in AI-based solutions. DXC also announced potential sale of its insurance business. Full-year revenue is projected to decline 5-5.5% YoY. (299 characters)